Psychopharmacology

, Volume 212, Issue 3, pp 301–307

Nicotine dependence and serum BDNF levels in male patients with schizophrenia

Authors

    • Center for Biological PsychiatryBeijing HuiLongGuan Hospital
    • Menninger Department of Psychiatry and Behavioral SciencesBaylor College of Medicine
    • VA Medical Center
  • Mei Hong Xiu
    • Center for Biological PsychiatryBeijing HuiLongGuan Hospital
  • Da Chun Chen
    • Center for Biological PsychiatryBeijing HuiLongGuan Hospital
  • Fu De Yang
    • Center for Biological PsychiatryBeijing HuiLongGuan Hospital
  • Gui Ying Wu
    • Menninger Department of Psychiatry and Behavioral SciencesBaylor College of Medicine
  • Lin Lu
    • National Institute on Drug DependencePeking University
  • Therese A. Kosten
    • Menninger Department of Psychiatry and Behavioral SciencesBaylor College of Medicine
    • Menninger Department of Psychiatry and Behavioral SciencesBaylor College of Medicine
    • VA Medical Center
original investigation

DOI: 10.1007/s00213-010-1956-y

Cite this article as:
Zhang, X.Y., Xiu, M.H., Chen, D.C. et al. Psychopharmacology (2010) 212: 301. doi:10.1007/s00213-010-1956-y

Abstract

Objective

Schizophrenia is associated with a significantly high prevalence of smoking. Upregulation of neurotrophins by nicotine is well established. Accumulating evidence shows that brain-derived neurotrophic factor (BDNF) may be involved in the pathophysiology of schizophrenia. The purposes of this study were to compare BDNF levels in smokers to nonsmokers with schizophrenia and examine the association between BDNF levels and psychopathological symptoms.

Materials and methods

Serum BDNF levels were measured in 139 male inpatients with DSM-IV schizophrenia: 102 smokers and 37 nonsmokers. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS).

Results

The positive PANSS symptoms were lower in smokers than in nonsmokers, while the negative symptoms were lower in those who smoked more cigarettes. BDNF levels were significantly higher in smokers than in nonsmokers (p < 0.05). Higher BDNF levels correlated with fewer negative symptoms and with smoking more cigarettes.

Conclusion

The fewer positive symptoms in smokers and fewer negative symptoms in those who smoked more cigarettes may be associated with nicotine-induced upregulation of BDNF.

Keywords

SchizophreniaSmokingNicotineBrain-derived neurotrophic factorNeurotrophin

Copyright information

© Springer-Verlag 2010